http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#head http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#provenance http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion http://rdf.disgenet.org/resource/gda/DGN2f7d1b9f07e076e15661c7a8a57c88d7 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/3845 http://rdf.disgenet.org/resource/gda/DGN2f7d1b9f07e076e15661c7a8a57c88d7 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0948380 http://rdf.disgenet.org/resource/gda/DGN2f7d1b9f07e076e15661c7a8a57c88d7 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#provenance http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion http://purl.org/dc/terms/description [Patients with metastatic colorectal cancer who had progressed on therapy with 5-FU, oxaliplatin and irinotecan in the first and second line setting and on the combination of irinotecan and cetuximab in third line setting independent of their KRAS mutation status, were treated with irinotecan and cetuximab combined with bevacizumab in a dosage of 5 mg/kg.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/21529301 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/dc/terms/created 2017-10-17T13:14:12+02:00 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0